Successful macular hole surgery

Article

Fixation stability influences the visual outcome following macular hole surgery, according to study results published in the January issue of Investigative Ophthalmology and Visual Science.

Fixation stability influences the visual outcome following macular hole surgery, according to study results published in the January issue of Investigative Ophthalmology and Visual Science.

Luminita Tarita-Nistor of Toronto Western Hopital and York University, Toronto, Canada and colleagues measured the visual acuity of patients (n=10) before and one and three months after surgery to correct macular hole. The researchers measured fixation stability and fixation location using the MP-1 Microperimeter (Nidek Technologies Srl), and quantified the degree of stability and amount of location shift.

Following surgery, the fixation location shifted a mean of 0.55º at one month and 0.87º at three months. This did not correlate with visual outcome. The fixation stability, however - which improved from 0.35º2 at one month to 0.29º2 at three months - was a good predictor of visual outcome.

The researchers concluded that the improvements in motor function following macular hole closure accounts for the improvement in visual function, and that a change in the stability of the fixation predicts the degree of visual improvement after this type of surgery.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.